medroxyprogesterone acetate has been researched along with Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jing, M; Lin, C; Tu, X; You, B; Zhang, R | 1 |
| Baştuğ, O; Güneş, T; Halis, H; Korkmaz, L; Kurtoğlu, S; Memur, S | 1 |
| Chen, H; Chen, Q; Kuang, Y; Lyu, Q; Wang, N; Wang, Y | 1 |
1 trial(s) available for medroxyprogesterone acetate and Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous
| Article | Year |
|---|---|
Controlled Ovarian Stimulation Using Medroxyprogesterone Acetate and hMG in Patients With Polycystic Ovary Syndrome Treated for IVF: A Double-Blind Randomized Crossover Clinical Trial.
Topics: Administration, Oral; Adult; Cross-Over Studies; Double-Blind Method; Embryo Transfer; Female; Fertilization; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone Acetate; Menotropins; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome; Prospective Studies; Sperm Injections, Intracytoplasmic | 2016 |
2 other study(ies) available for medroxyprogesterone acetate and Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous
| Article | Year |
|---|---|
Progestin-Primed Ovarian Stimulation Versus Mild Stimulation Protocol in Advanced Age Women With Diminished Ovarian Reserve Undergoing Their First
Topics: Adult; Chorionic Gonadotropin; Clomiphene; Cohort Studies; Dydrogesterone; Female; Fertility Agents, Female; Fertilization in Vitro; Humans; Letrozole; Live Birth; Maternal Age; Medroxyprogesterone Acetate; Menotropins; Odds Ratio; Oocyte Retrieval; Ovarian Hyperstimulation Syndrome; Ovarian Reserve; Ovulation Induction; Pregnancy; Pregnancy Rate; Progestins; Retrospective Studies; Sperm Injections, Intracytoplasmic; Triptorelin Pamoate | 2021 |
Ovarian hyperstimulation syndrome treated by medroxyprogesterone acetate.
Topics: Female; Humans; Infant, Newborn; Medroxyprogesterone Acetate; Ovarian Hyperstimulation Syndrome; Treatment Outcome | 2014 |